PRIA Healthcare News and Insights

You Got Your 510(k). Now What?

Right Sizing Your Quality System

Five Mistakes MedTech StartUps Make Before Their First VAC Meeting

Using Regulatory as a Strategy and Not a Milestone

An informative article series from PRIA Healthcare's Head of Regulatory and Quality, Sam Murray

PRIA examines the impact of the RAPID program, accelerating Medicare access for Breakthrough Devices by aligning FDA approval & CMS coverage, earlier, on innovators.

PRIA's experts on reimbursement and regulatory issues weigh in on CMS's proposed NTAP change, and what it may mean for MedTech innovations.

PRIA Healthcare is thrilled to announce that Sam Murray has joined PRIA as our Head of Regulatory and Quality. Sam brings more than a decade of experience doing exactly that kind of high-stakes, high-impact regulatory work across medical devices, diagnostics, combination products, and software-enabled technologies.

MedTech reimbursement and market access, core drivers of valuation, acquisition potential, and long-term viability, should be developed in sync with your regulatory strategy